作者: Bat-Sheva L. Maslow , Christopher B. Morse , Allison Schanne , Alison Loren , Susan M. Domchek
DOI: 10.1016/J.CONTRACEPTION.2014.03.002
关键词:
摘要: Abstract Objective Few data on contraceptive choices in women with cancer exist. Contraception is challenging for cancer, particularly those breast who are limited to nonhormonal methods. This study characterized use during treatment a group of reproductive-aged recent diagnosis and assessed the impact counseling methods they selected. Study Design Cross-sectional, survey at large tertiary care health system diagnosis. Results A total 107 completed survey. Eighty-two reported 101 choices. Twenty-seven percent (27/101) all selected were Tier I/II, 35% (35/101) III/IV. Only 4 used an intrauterine device (IUD). Among reporting sexual activity after diagnosis, 19 (27%) 71 using I/II methods, 21 (30%) III/IV 16 (23%) abstinence 10 (14%) no method. Factors significantly associated multivariable model included not having college degree [odds ratio (OR) 0.21, 95% confidence interval (CI) 0.05–0.92, p=.038], intercourse (OR 5.92, CI 1.48–23.66, p=.012) non-breast 3.60, 1.03–12.64, p=.046). Report was positively 6.92, 1.14–42.11, p=.036). Conclusion Reproductive-aged diagnosed underutilized agents, especially IUDs. Contraceptive by physicians increases use, most effective preventing pregnancy. Implications The uniquely described practices over 100 cancer. sample commonly high failure rates. Our suggest that from provider may increase more among